Itaconix plc
ITX.L
London Stock Exchange109.70
GBp
-1.30
- -
Itaconix plc
ITX.L
(London Stock Exchange)
Recent
price
109.70
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Itaconix plc develops and manufactures proprietary plant-based specialty polymers that improve the performance and sustainability of consumer products, primarily serving home care, personal care, paints, coatings, and adhesives markets. Its core product offerings include multifunctional scale inhibitors for detergents under the Itaconix® brand, odour-neutralizing polymers marketed as VELAFRESH® and ITACONIX® ONZ™ series, and new specialty monomers and binders launched under the BIOAsterix® line targeting high-value industrial coatings and adhesives sectors. The company operates through two main segments: Performance Ingredients and Formulated Solutions, delivering ingredients globally, with commercial presence in North America, Europe, and Asia. Itaconix also recently initiated the SPARX™ innovation program aimed at accelerating the development and market adoption of new plant-based ingredient formulations in collaboration with other specialty ingredient firms and consumer brands. Founded in 2005 and headquartered in Stratham, New Hampshire, Itaconix transitioned from its former name Revolymer plc in 2017 and has expanded its geographic and product footprint since. Recent major developments include a significant revenue growth trajectory with a 73% increase in H1 2025 revenues to $4.8 million, driven largely by cleaning product sales and initial traction in formulated product offerings through SPARX™. In June 2025, Itaconix commercially launched the BIOAsterix® product line, adding a third distinct revenue stream beyond its cleaning and formulated solutions businesses. The company also extended and expanded its global supply and marketing collaboration with Croda Inc., including a new ingredient focused on odour control in fabric cleaning. Itaconix has broadened regulatory approvals in Australia, New Zealand, South Korea, Europe, and China, supporting global expansion. The firm invests in manufacturing improvements to enhance efficiency and packaging, maintaining production capacity in the U.S. without plans for new facilities. The expanded product portfolio now includes 17 proprietary products protected by 16 patent families, underpinning sustainable growth in multiple segments. Itaconix’s products are aimed at consumer and industrial customers seeking to reduce environmental impact and enhance the efficacy of cleaning, hygiene, beauty, and coating products. The SPARX™ program targets launching at least 10 new consumer products by the end of 2025, collaborating with ingredient suppliers, contract manufacturers, and brands. The company’s strategic focus is on regaining and expanding market share in North America and Europe for detergent polymers, increasing hygiene and beauty segment sales, and establishing new applications for odour neutralization and industrial use. Its strong balance sheet, proprietary technology platform, expanding product pipeline, and global regulatory footprint position Itaconix for sustained revenue growth and profitability advancement in the specialty polymer space. The company remains vigilant on macroeconomic and trade policy influences while driving innovation and commercial partnerships. This comprehensive portfolio and strategic momentum reflect Itaconix plc’s leadership in sustainable, plant-based specialty polymers for global consumer and industrial markets, with ongoing expansion into new sectors and geographies through innovative product launches and collaborative programs.